Literature DB >> 22642778

Off-label prescribing in older people: the need for increased awareness and caution.

Anne Stephenson1, Geoffrey M Anderson, Paula Rochon.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22642778     DOI： 10.2165/11634620-000000000-00000

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  5 in total

Review 1.  Off-label prescribing in older patients.

Authors:  Stephen H D Jackson; Paul A F Jansen; Arduino A Mangoni
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  Antipsychotic therapy and short-term serious events in older adults with dementia.

Authors:  Paula A Rochon; Sharon-Lise Normand; Tara Gomes; Sudeep S Gill; Geoffrey M Anderson; Magda Melo; Kathy Sykora; Lorraine Lipscombe; Chaim M Bell; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2008-05-26

3.  Regulating off-label drug use--rethinking the role of the FDA.

Authors:  Randall S Stafford
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

4.  U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.

Authors:  Donna T Chen; Matthew K Wynia; Rachael M Moloney; G Caleb Alexander
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-11       Impact factor: 2.890

5.  Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.

Authors:  Elmira Valiyeva; Nathan Herrmann; Paula A Rochon; Sudeep S Gill; Geoffrey M Anderson
Journal:  CMAJ       Date:  2008-08-26       Impact factor: 8.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.